These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7921854)

  • 1. Detection of transfusion-associated hepatitis caused by non-A, non-B, non-C flavivirus.
    Takács M; Berencsi G; Mezey I; Brojnás J; Barcsay E; Garamvölgyi E; Hütter E; Ferenczi E; Pipirász E; Hollós I
    Acta Microbiol Immunol Hung; 1994; 41(1):83-9. PubMed ID: 7921854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transfusion-associated non-A, non-B, non-C hepatitis caused by flaviviruses].
    Takács M; Berencsi G; Mezey I; Murányiné Brojnás J; Barcsay E; Ferenczi E; Hollós I; Dömök I
    Orv Hetil; 1992 Jul; 133 Suppl 1():37-9. PubMed ID: 1321397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
    Ludolfs D; Reinholz M; Schmitz H
    J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.
    Chemello L; Cavalletto D; Pontisso P; Bortolotti F; Donada C; Donadon V; Frezza M; Casarin P; Alberti A
    Hepatology; 1993 Feb; 17(2):179-82. PubMed ID: 8381380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement].
    Misić-Majerus L; Bujić N; Madarić V; Avsić-Zupanc T
    Acta Med Croatica; 2005; 59(4):347-52. PubMed ID: 16334744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusogenic peptide as diagnostic marker for detection of flaviviruses.
    Pattnaik P; Srivastava A; Abhyankar A; Dash PK; Parida MM; Lakshmana Rao PV
    J Postgrad Med; 2006; 52(3):174-8. PubMed ID: 16855316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of Yokose virus, a flavivirus isolated from the bat in Japan.
    Tajima S; Takasaki T; Matsuno S; Nakayama M; Kurane I
    Virology; 2005 Feb; 332(1):38-44. PubMed ID: 15661139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive killer T lymphocytes in a flavivirus infection.
    Gajdosová E; Mayer V; Oravec C
    Acta Virol; 1980 Jun; 24(4):291-3. PubMed ID: 6106380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of non-A-E hepatitis: possible role of hepatitis B and C virus infection.
    He Z; Zhuang H; Wang X; Song S; Dong Q; Yan J; Buehring GC; Luo G
    J Med Virol; 2003 Jan; 69(1):59-65. PubMed ID: 12436478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavivirus serology by Western blot analysis.
    Oceguera LF; Patiris PJ; Chiles RE; Busch MP; Tobler LH; Hanson CV
    Am J Trop Med Hyg; 2007 Jul; 77(1):159-63. PubMed ID: 17620648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis.
    Koretz RL; Brezina M; Polito AJ; Quan S; Wilber J; Dinello R; Gitnick G
    Hepatology; 1993 Mar; 17(3):361-5. PubMed ID: 8383087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse and hamster models for the study of therapy against flavivirus infections.
    Charlier N; De Clercq E; Neyts J
    Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flavivirus encephalitis: focus on West Nile encephalitis].
    Lim CK; Takasaki T
    Rinsho Byori; 2005 Aug; 53(8):721-7. PubMed ID: 16190358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.